Thomas Ciulla - Net Worth and Insider Trading

Thomas Ciulla Net Worth

The estimated net worth of Thomas Ciulla is at least $312,322 dollars as of 2024-11-06. Thomas Ciulla is the Chief Medical Officer of Clearside Biomedical Inc and owns about 291,890 shares of Clearside Biomedical Inc (CLSD) stock worth over $312,322. Details can be seen in Thomas Ciulla's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Ciulla has not made any transactions after 2023-01-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Thomas Ciulla

To

Thomas Ciulla Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Ciulla owns 1 companies in total, including Clearside Biomedical Inc (CLSD) .

Click here to see the complete history of Thomas Ciulla’s form 4 insider trades.

Insider Ownership Summary of Thomas Ciulla

Ticker Comapny Transaction Date Type of Owner
CLSD Clearside Biomedical Inc 2023-01-20 Chief Medical Officer

Thomas Ciulla Latest Holdings Summary

Thomas Ciulla currently owns a total of 1 stock. Thomas Ciulla owns 291,890 shares of Clearside Biomedical Inc (CLSD) as of January 20, 2023, with a value of $312,322.

Latest Holdings of Thomas Ciulla

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLSD Clearside Biomedical Inc 2023-01-20 291,890 1.07 312,322

Holding Weightings of Thomas Ciulla


Thomas Ciulla Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Ciulla has made a total of 4 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Clearside Biomedical Inc is the sale of 13,700 shares on January 20, 2023, which brought Thomas Ciulla around $20,139.

Insider Trading History of Thomas Ciulla

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Ciulla Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Ciulla Ownership Network

Ownership Network List of Thomas Ciulla

No Data

Ownership Network Relation of Thomas Ciulla

Insider Network Chart

Thomas Ciulla Owned Company Details

What does Clearside Biomedical Inc do?

Who are the key executives at Clearside Biomedical Inc?

Thomas Ciulla is the Chief Medical Officer of Clearside Biomedical Inc. Other key executives at Clearside Biomedical Inc include 10 percent owner Bradford T Whitmore , Chief Financial Officer Charles A. Deignan , and director & 10 percent owner Clay Thorp .

Clearside Biomedical Inc (CLSD) Insider Trades Summary

Over the past 18 months, Thomas Ciulla made no insider transaction in Clearside Biomedical Inc (CLSD). Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 90,000 shares made by , a net purchase of 580,222 shares made by Bradford T Whitmore , and a net purchase of 100,000 shares made by Anthony S Gibney .

In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 36,500 shares, with a net purchase of 36,500 shares. During the past 18 months, 30,900 shares of Clearside Biomedical Inc (CLSD) were sold and 798,035 shares were bought by its insiders, resulting in a net purchase of 767,135 shares.

Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Clearside Biomedical Inc Insider Transactions

No Available Data

Thomas Ciulla Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Ciulla. You might contact Thomas Ciulla via mailing address: C/o Clearside Biomedical, Inc., 900 North Point Parkway, Suite 200, Alpharetta Ga 30005.